In addition, TRAF2 was found to be strongly associated with immune cell infiltration in tumor microenvironment and efficacy of immunotherapy, with particular association with T cells, which was experimentally validated in hepatocellular carcinoma. The gene discussed is TRAF2; the disease is hepatocellular carcinoma.